Osteoblast-derived oxysterol is a migration-inducing factor for human breast cancer cells.
Jeane Silva, Anke Beckedorf, Erhard Bieberich
Index: J. Biol. Chem. 278(28) , 25376-85, (2003)
Full Text: HTML
Abstract
Bone metastasis is the major reason for death caused by breast cancer. We used human breast cancer (MCF-7) cells that are poorly metastatic but show highly inducible migration to determine bone-derived factors that induce migration of initially non-disseminating breast cancer cells. We have found that a lipid fraction from human osteoblast-like MG63 cell-conditioned medium (MG63CM) contains a migration-inducing factor for MCF-7 cells. In this fraction, we have identified oxysterol (OS) as a lipid mediator for tumor cell migration. In MCF-7 cells, insulin-like growth factor 1 elevates the expression of OS-binding protein-related protein 7. Binding of OS to OS-binding protein or OS-binding protein-related protein is known to trigger elevation of sphingomyelin, a sphingolipid that organizes lipid microdomains in the cell membrane. In MCF-7 cells, OS increases the intracellular concentration of sphingomyelin and other phospholipids and induces the translocation of the small GTPase p21Ras to GM1- and cholesterol-rich membrane areas. The induction of migration by MG63CM is prevented by incubation of MG63 cells with mevinolin, a statin-type cholesterol biosynthesis inhibitor that depletes the conditioned medium of OS. Osteoblast-derived OS may, thus, be a yet unrecognized lipid mediator for bone metastasis of breast cancer and a new target for anti-metastasis chemotherapy with statins.
Related Compounds
Related Articles:
2015-08-01
[J. Lipid Res. 56 , 1419-33, (2015)]
2015-07-01
[J. Agric. Food Chem. 63 , 5957-63, (2015)]
Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.
2014-07-15
[Stem Cells Dev. 23(14) , 1582-93, (2014)]
Prostaglandin B(2) delivers a co-stimulatory signal leading to T cell activation.
2000-09-01
[Eur. Cytokine Netw. 11(2) , 293-9, (2000)]
Ca2+ mobilization with leukotriene A4 and epoxytetraenes in human neutrophils.
1990-01-15
[Biochem. Pharmacol. 39(2) , 355-65, (1990)]